Ventricular function and tissue characterization by cardiac magnetic resonance imaging following hospitalization for multisystem inflammatory syndrome in children: a prospective study

[1]  G. Di Salvo,et al.  Myocardial involvement in children with post-COVID multisystem inflammatory syndrome: a cardiovascular magnetic resonance based multicenter international study—the CARDOVID registry , 2021, Journal of Cardiovascular Magnetic Resonance.

[2]  H. Seiden,et al.  Mid-Term Outcomes and Cardiac Magnetic Resonance Imaging Following Multisystem Inflammatory Syndrome in Children. , 2021, The Journal of pediatrics.

[3]  R. Friedman,et al.  Six Month Follow-up of Patients With Multi-System Inflammatory Syndrome in Children , 2021, Pediatrics.

[4]  G. Di Salvo,et al.  Early Echocardiographic and Cardiac MRI Findings in Multisystem Inflammatory Syndrome in Children , 2021, Journal of clinical medicine.

[5]  Kanwal M. Farooqi,et al.  Longitudinal Outcomes for Multisystem Inflammatory Syndrome in Children , 2021, Pediatrics.

[6]  K. Rychlik,et al.  Cardiovascular magnetic resonance imaging in children after recovery from symptomatic COVID-19 or MIS-C: a prospective study , 2021, Journal of Cardiovascular Magnetic Resonance.

[7]  S. Kabir,et al.  Multimodality cardiac evaluation in children and young adults with multisystem inflammation associated with COVID-19 , 2020, European heart journal cardiovascular Imaging.

[8]  P. Zachariah,et al.  Multisystem Inflammatory Syndrome Related to COVID-19 in Previously Healthy Children and Adolescents in New York City. , 2020, JAMA.

[9]  F. Rovida,et al.  Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection in Children and Adolescents: A Systematic Review. , 2020, JAMA pediatrics.

[10]  Matthias Gutberlet,et al.  Cardiovascular Magnetic Resonance in Nonischemic Myocardial Inflammation: Expert Recommendations. , 2018, Journal of the American College of Cardiology.

[11]  Richard B. Thompson,et al.  Clinical recommendations for cardiovascular magnetic resonance mapping of T1, T2, T2* and extracellular volume: A consensus statement by the Society for Cardiovascular Magnetic Resonance (SCMR) endorsed by the European Association for Cardiovascular Imaging (EACVI) , 2017, Journal of Cardiovascular Magnetic Resonance.

[12]  D. Messroghli,et al.  Myocardial T1 Mapping in Pediatric and Congenital Heart Disease , 2015, Circulation. Cardiovascular imaging.

[13]  M. Robson,et al.  Myocardial T1 mapping and extracellular volume quantification: a Society for Cardiovascular Magnetic Resonance (SCMR) and CMR Working Group of the European Society of Cardiology consensus statement , 2013, Journal of Cardiovascular Magnetic Resonance.

[14]  Andrew S Flett,et al.  Comprehensive Validation of Cardiovascular Magnetic Resonance Techniques for the Assessment of Myocardial Extracellular Volume , 2013, Circulation. Cardiovascular imaging.

[15]  P. Kellman,et al.  Association Between Extracellular Matrix Expansion Quantified by Cardiovascular Magnetic Resonance and Short-Term Mortality , 2012, Circulation.

[16]  M. Hayward,et al.  Equilibrium Contrast Cardiovascular Magnetic Resonance for the Measurement of Diffuse Myocardial Fibrosis: Preliminary Validation in Humans , 2010, Circulation.

[17]  Clare Jackson,et al.  Journal of Cardiovascular Magnetic Resonance Open Access Normal Right-and Left Ventricular Volumes and Myocardial Mass in Children Measured by Steady State Free Precession Cardiovascular Magnetic Resonance , 2009 .

[18]  S. Chugh,et al.  Gadolinium-enhanced magnetic resonance imaging for detection and quantification of fibrosis in human myocardium in vitro , 2007, The International Journal of Cardiovascular Imaging.

[19]  Michael Jerosch-Herold,et al.  T1 Mapping: Basic Techniques and Clinical Applications. , 2016, JACC. Cardiovascular imaging.

[20]  M. Link,et al.  Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 3: Hypertrophic Cardiomyopathy, Arrhythmogenic Right Ventricular Cardiomyopathy and Other Cardiomyopathies, and Myocarditis: A Scientific Statement From the American Heart Associat , 2015, Journal of the American College of Cardiology.